Literature DB >> 6305013

Herpes simplex virus latency and reactivation in isolated rat sensory neurons.

B L Wigdahl, R J Ziegler, M Sneve, F Rapp.   

Abstract

An in vitro herpes simplex virus type 1 (HSV-1) latency model has been established using neurons isolated from dissociated rat fetus sensory ganglia as the host cell. Rat fetal neuron cells were pretreated for 24 hr at 37 degrees with (E)-5-(2-bromovinyl)-2'-deoxyuridine and human leukocyte interferon, infected with HSV-1 (approximately 2.5 plaque-forming units/cell), and treated for 7 days with the same inhibitor combination. Infectious HSV-1 became undetectable 3 days postinfection and remained undetectable during the remainder of the inhibitor treatment. After removal of inhibitors on day 7, infectious virus remained undetectable for 2-7 days; subsequently, virus replication ensued and neuronal cells were destroyed. Incubation of inhibitor-treated, infected neuron cells at 40.5 degrees after removal of inhibitors resulted in extension of the latent period to at least 15 days. HSV-1 was reactivated from latently infected neurons by reducing the incubation temperature from 40.5 to 37 degrees and virus-specific cytopathology was observed in neurons within 96 hr after reducing temperature. This in vitro model system will provide the first system to analyze, in a primary cell type of neuronal origin, the state of the HSV genome during establishment and maintenance of the latent state and during virus reactivation.

Entities:  

Mesh:

Year:  1983        PMID: 6305013     DOI: 10.1016/0042-6822(83)90380-x

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  21 in total

Review 1.  Human herpesviruses: a consideration of the latent state.

Authors:  J G Stevens
Journal:  Microbiol Rev       Date:  1989-09

2.  Amplification of herpes simplex virus resistance in mouse neuroblastoma (Cl300) cells.

Authors:  E Nilheden; S Jeansson; A Vahlne
Journal:  Arch Virol       Date:  1985       Impact factor: 2.574

3.  Herpes simplex virus latency in a hyperresistant clone of mouse neuroblastoma (Cl300) cells.

Authors:  E Nilheden; S Jeansson; A Vahlne
Journal:  Arch Virol       Date:  1985       Impact factor: 2.574

4.  Nerve growth factor deprivation results in the reactivation of latent herpes simplex virus in vitro.

Authors:  C L Wilcox; E M Johnson
Journal:  J Virol       Date:  1987-07       Impact factor: 5.103

5.  Macromolecular synthesis at the early stage of herpes simplex virus type 2 (HSV-2) latency in a human neuroblastoma cell line IMR-32: repression of late viral polypeptide synthesis and accumulation of cellular heat-shock proteins.

Authors:  Y Yura; K Terashima; H Iga; Y Kondo; T Yanagawa; H Yoshida; Y Hayashi; M Sato
Journal:  Arch Virol       Date:  1987       Impact factor: 2.574

6.  Infection of human fetal dorsal root ganglion glial cells with human immunodeficiency virus type 1 involves an entry mechanism independent of the CD4 T4A epitope.

Authors:  C Kunsch; H T Hartle; B Wigdahl
Journal:  J Virol       Date:  1989-12       Impact factor: 5.103

7.  Efficient quiescent infection of normal human diploid fibroblasts with wild-type herpes simplex virus type 1.

Authors:  Robert McMahon; Derek Walsh
Journal:  J Virol       Date:  2008-08-13       Impact factor: 5.103

8.  Neurons versus herpes simplex virus: the innate immune interactions that contribute to a host-pathogen standoff.

Authors:  Pamela C Rosato; David A Leib
Journal:  Future Virol       Date:  2015-06       Impact factor: 1.831

9.  Herpes simplex virus latency in isolated human neurons.

Authors:  B Wigdahl; C A Smith; H M Traglia; F Rapp
Journal:  Proc Natl Acad Sci U S A       Date:  1984-10       Impact factor: 11.205

10.  Induction of cellular stress overcomes the requirement of herpes simplex virus type 1 for immediate-early protein ICP0 and reactivates expression from quiescent viral genomes.

Authors:  Chris M Preston; Mary Jane Nicholl
Journal:  J Virol       Date:  2008-09-17       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.